- Topic
45k Popularity
3k Popularity
2k Popularity
33k Popularity
63k Popularity
- Pin
- 🎉【Gate Singapore Flagship Event · Square Fun Quiz Challenge Day 1】
#TOKEN2049# is just around the corner, and Gate is bringing the heat to Singapore!
Token of Love Music Festival, Gate x Oracle Red Bull Racing Reception, and the F1 Race Viewing are all set to roll out!
Join Square Fun Quiz Challenge now, test how much you know about the events and share $100 BTC in rewards!
To join: Comment your answers (format: 1B 2A 3B 4C)
🎁 Rewards: 3 lucky winners each day → $10 BTC each
👑 Bonus: Answer all questions correctly for 3 days → Extra $10 BTC for Super Quiz King!
📖 Day 1 · Quiz (Single Choic - 💥 Gate Square Event: #SOMI Creative Contest# 💥
Post original content related to SOMI or CandyDrop #76 on Gate Square for a chance to share 180 SOMI rewards!
CandyDrop 76: CandyDrop x Somnia (SOMI)👉 https://www.gate.com/announcements/article/46912
📅 Event Period: Sep 8, 2025 – Sep 15, 2025
📌 How to Participate:
Post original content related to SOMI or the CandyDrop event
Minimum 80 words
Add hashtag: #SOMI Creative Contest#
Include CandyDrop participation screenshot
🏆 Rewards:
🥇 1st Prize (1 winner): 60 SOMI
🥈 2nd Prize (3 winners): 30 SOMI each
🥉 3rd Prize (6 winners): 10 SOMI each
(T - 🚗 #GateSquareCommunityChallenge# Round 1 — Who Will Be The First To The Moon?
Brain challenge, guess and win rewards!
5 lucky users with the correct answers will share $50 GT! 💰
Join:
1️⃣ Follow Gate_Square
2️⃣ Like this post
3️⃣ Drop your answer in the comments
📅 Ends at 16:00, Sep 17 (UTC)
Hanyu Pharmaceutical: The enrollment of all subjects in the Phase III clinical trial for the weight loss indication of Semaglutide Injection has been completed.
On June 12, Hanyu Pharmaceutical said on the interactive platform that the company's semaglutide injection was declared for marketing in accordance with Class 2.2, of which the bariatric indication had completed the enrollment of all subjects in the phase III clinical trial in January this year, and was currently in the follow-up stage, and the project had entered the dose maintenance period. After the completion of the Phase III clinical trial in the future, the Company will submit a marketing application after collating and improving the clinical trial data in accordance with relevant regulatory requirements.